| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 07/13/2000 | WO2000040548A1 Arylalkanoyl derivatives, processes for their preparation, their use and pharmaceutical compositions containing them |
| 07/13/2000 | WO2000040247A1 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 07/13/2000 | WO2000021927A3 Pyrrole-2,5-diones as gsk-3 inhibitors |
| 07/13/2000 | WO2000006597A9 Endogenous constitutively activated g protein-coupled orphan receptors |
| 07/13/2000 | DE19900519A1 Substituierte Guanidin-Derivate Substituted guanidine derivatives |
| 07/13/2000 | DE19900355A1 New 2-(naphthalen-2-ylmethyl)-benzimidazole derivatives are Factor VIIa, IXa, Xa and thrombin inhibitors useful for treating thrombosis and other cardiovascular disorders, inflammation and apoplexy |
| 07/13/2000 | DE19845405C2 Arylsubstituierte Propanolaminderivate und deren Verwendung Aryl-substituted Propanolaminderivate and their use |
| 07/13/2000 | CA2358576A1 Cyclic guanidine derivatives and their use as pesticides |
| 07/13/2000 | CA2355308A1 3,4-dihydro-2h-benzo¬1,4|oxazinyl-methyl¬3-(1h-indol-3-yl)-alkyl|-amines |
| 07/13/2000 | CA2353636A1 Quinolinecarboxamides as antiviral agents |
| 07/12/2000 | EP1018008A2 Method of identification of leads or active compounds |
| 07/12/2000 | EP1017691A1 Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
| 07/12/2000 | EP1017395A1 Method for treating premenstrual or late luteal phase syndrome |
| 07/12/2000 | EP0745073B1 5-substituted derivatives of mycophenolic acid |
| 07/12/2000 | EP0628041B1 Heterocyclic compounds and their preparation and use |
| 07/12/2000 | CN1259943A Substituted aryluracils |
| 07/12/2000 | CN1259942A Novel guanidine mimics as factor Xa inhibitors |
| 07/12/2000 | CN1259935A Substituted naphthopyrans |
| 07/11/2000 | US6087502 Acridinium compound having a plurality of luminescent groups and binding groups, and conjugate thereof |
| 07/11/2000 | US6087496 Enzyme inhibitors |
| 07/11/2000 | US6087384 Treating prophylaxis and treatment of a disease associate with death of cells caused by viral diseases, myelodysplasis, neurodegenerative, ischemic and hepatic diseases with a compound having an insulin sensitivity enhancing activity |
| 07/11/2000 | US6087365 Treating drug-resistant malaria in a mammal |
| 07/11/2000 | US6087357 Piperazine derivatives as tachykinin antagonists |
| 07/06/2000 | WO2000039126A1 Method for preparing (r)- (+) -3 {1- [2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl}-1,1- dimethylurea, its salts solvates and/or hydrates |
| 07/06/2000 | WO2000039125A1 Piperidines as ccr5 modulators |
| 07/06/2000 | WO2000039124A1 Thrombin inhibitors |
| 07/06/2000 | WO2000039114A2 Substituted oximes and hydrazones as neurokinin antagonists |
| 07/06/2000 | WO2000039108A1 Thrombin or factor xa inhibitors |
| 07/06/2000 | WO2000039102A1 THROMBIN OR FACTOR Xa INHIBITORS |
| 07/06/2000 | WO2000039101A1 Pyrimidine compounds |
| 07/06/2000 | WO2000039091A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/06/2000 | WO2000039089A1 3-azabicyclo[3.1.0.] hexane derivatives as opiate receptors ligands |
| 07/06/2000 | WO2000039087A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors |
| 07/06/2000 | WO2000039081A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 07/06/2000 | WO2000038786A2 Use of cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO2000038730A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
| 07/06/2000 | WO2000038719A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | WO2000038718A2 Use of matrix metalloproteinase inhibitor together with an antineoplastic agents, optionally also together with radiation, in the treatment of neoplasia |
| 07/06/2000 | WO2000038717A2 Use of a matrix metalloproteinase inhibitor and radiation as a combined treatment of neoplasia |
| 07/06/2000 | WO2000038715A2 Use of an integrin antagonist and radiation in the treatment of neoplasia |
| 07/06/2000 | WO2000038687A1 Protease inhibitors |
| 07/06/2000 | WO2000038683A1 THROMBIN OR FACTOR Xa INHIBITORS |
| 07/06/2000 | WO2000038680A1 Azabicycloalkanes as ccr5 modulators |
| 07/06/2000 | WO2000038665A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | WO1999064035A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 07/06/2000 | CA2358047A1 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds |
| 07/06/2000 | CA2356929A1 Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combonation therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356748A1 Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356671A1 Protease inhibitors |
| 07/06/2000 | CA2356606A1 Method of using a cyclooxygenase-2 inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356462A1 Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356459A1 Method of using a matrix metalloproteinase inhibitor and radiation therapy as combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2356402A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia |
| 07/06/2000 | CA2356302A1 Method of using a cyclooxygenase-2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia |
| 07/06/2000 | CA2355281A1 Thrombin inhibitors |
| 07/06/2000 | CA2352896A1 Pyrimidine compounds |
| 07/06/2000 | CA2351539A1 Method for preparing (r)- (+) -3 {1- ¬2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl|- 4-phenylpiperidin -4-yl}-1,1- dimethylurea, its salts solvates and/or hydrates |
| 07/06/2000 | CA2350589A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 07/06/2000 | CA2349557A1 Thrombin or factor xa inhibitors |
| 07/06/2000 | CA2348740A1 Thrombin or factor xa inhibitors |
| 07/06/2000 | CA2320730A1 Thrombin or factor xa inhibitors |
| 07/05/2000 | EP1015447A1 Piperidinylmethyloxazolidinone derivative |
| 07/05/2000 | EP1015446A1 (4-piperidinyl)-1h-2-benzopyran derivatives useful as antipsychotic agents |
| 07/05/2000 | EP1015437A1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals |
| 07/05/2000 | EP1015436A1 Morpholinones as light stabilizers |
| 07/05/2000 | EP1015429A1 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa |
| 07/05/2000 | EP1014982A1 Troglitazone compounds for treating climacteric |
| 07/05/2000 | EP1014973A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 07/05/2000 | EP0882138B1 Stereoselective preparation of 2-substituted succinic derivatives |
| 07/05/2000 | EP0734381B1 Morpholine tachykinin receptor antagonists |
| 07/05/2000 | EP0692982B1 RADIOLABELED PLATELET GPIIb/IIIa RECEPTOR ANTAGONISTS AS IMAGING AGENTS FOR THE DIAGNOSIS OF THROMBOEMBOLIC DISORDERS |
| 07/05/2000 | EP0686151B1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
| 07/05/2000 | EP0675886B1 Aminomethylene substituted non-aromatic heterocycles and use as substance p antagonists |
| 07/05/2000 | CN1259129A Desoxycyclodepsipeptides and their use for combatting endoparasites |
| 07/05/2000 | CN1259128A Thiodepsipeptides for combating endoparasites and a method for producing the same |
| 07/05/2000 | CN1259125A Substituted 3-cyano quinolines |
| 07/05/2000 | CN1259122A Method for producing chiral 3,4-dehydroprolines |
| 07/04/2000 | US6084130 For treatment of central nervous system disorders |
| 07/04/2000 | US6084103 Forming a carbamate from methyl 4-nitro-(l)-phenylalaninate hydrochloride; reducing the nitro and ester groups; ring closure free of phosgene; forming a diazonium salt without using tin chloride; fischer reaction; migraines; 5ht1-agonist |
| 07/04/2000 | US6083967 Antimicrobial agents; assay for determining the inhibitory activity of oxazolidinones to human monoamine oxidase |
| 07/04/2000 | US6083965 Antiparasitic agents |
| 07/04/2000 | US6083961 For prevention and/or treatment of bradykinin or its analogues mediated diseases such as allergy, inflammation, autoimmune disease, shock, pain |
| 07/04/2000 | US6083944 Enzyme inhibitors; treatment of various debilitating disorders |
| 07/04/2000 | US6083942 Pesticidal hetero-substituted oxadiazine compounds |
| 07/04/2000 | US6083881 Pyrazole derivatives as herbicides |
| 06/29/2000 | WO2000037473A1 Epothilone derivatives and their use as antitumor agents |
| 06/29/2000 | WO2000037464A2 4-(aminoalkoxy)benzofurans as n-myristoyltransferase inhibitors |
| 06/29/2000 | WO2000037462A1 Non-peptide nk1 receptors antagonists |
| 06/29/2000 | WO2000037458A1 Farnesyl protein transferase inhibitors |
| 06/29/2000 | WO2000037422A2 Ion channel modulating agents |
| 06/29/2000 | WO2000037107A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combination treatment of neoplasia |
| 06/29/2000 | WO1999064034A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 06/29/2000 | CA2356426A1 Method of using a cyclooxygenase-2 inhibitor and a matrix metalloproteinase inhibitor as a combination therapy in the treatment of neoplasia |
| 06/29/2000 | CA2355694A1 Novel bicyclic compounds |
| 06/29/2000 | CA2355137A1 Non-peptide nk1 receptors antagonists |
| 06/28/2000 | EP1014186A1 Photographic yellow dye-forming couplers |
| 06/28/2000 | EP1013276A1 Aminoazacycloalkanes as CCR5 modulators |
| 06/28/2000 | EP1012150A1 Heteroarylcarboxamide compounds active against protein tyrosine kinase related disorders |
| 06/28/2000 | EP1011667A1 Antagonists of gonadotropin releasing hormone |
| 06/28/2000 | CN1258296A Pyridine derivatives and pharmaceutical compositions contg. them |